Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07156461 · ClinicalTrials.gov registry record · NA
Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT07156461 is a NA study that has completed, run by Cochlear. The registered enrollment target is 29 participants.
The verdict
NCT07156461, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The goal of this interventional study is to evaluate the clinical performance and sound quality of the Osia 3 Sound Processor and to demonstrate its superiority compared with the Osia 2 Sound Processor in adults with mixed hearing loss, conductive hearing loss, or single-sided deafness. The main questions this study aims to answer are: * Do the findings confirm the clinical performance of the Osia 3 Sound Processor? * Is the Osia 3 Sound Processor superior compared to the Osia 2 Sound Processor? Participants will: * Undergo speech performance testing in both quiet and noisy environments * Provide ratings for a self-reported questionnaire
Interventions
- DEVICE Cochlear™ Osia® System (Osia® 2)
- DEVICE Cochlear™ Osia® System (Osia® 3)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2025-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07156461
The ClinicalTrials.gov registry entry for NCT07156461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cochlear™ Osia® System (Osia® 2) is the first listed.
NCT07156461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07156461 about?
NCT07156461 is a clinical study titled "Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients". The goal of this interventional study is to evaluate the clinical performance and sound quality of the Osia 3 Sound Processor and to demonstrate its superiority compared with the Osia 2 Sound Processor in adults with mixed hearing loss, conductive hearing loss, or single-sided deafness. The main qu...
What is the current status of trial NCT07156461?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2025-09-09. Estimated completion is 2025-11-24.
What interventions are being tested in trial NCT07156461?
The interventions under investigation include: Cochlear™ Osia® System (Osia® 2) (DEVICE), Cochlear™ Osia® System (Osia® 3) (DEVICE).
Who is sponsoring clinical trial NCT07156461?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.